Tvardi Therapeutics, Inc. Income Statement
TVRD|11 years of annual SEC 10-K data (FY2014-FY2024)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 11 fiscal years. All figures from audited SEC 10-K filings.
Tvardi Therapeutics, Inc. reported $42M in revenue and $85M in net loss for FY2024. Revenue has grown at a 42.8% compound annual rate over the past 10 years.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -6.41 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41.9M | $23.0M | $135.1M | $19.9M | $13.5M | $911.0K | $86.0K | $3.8M | $3.2M | $12.0M | $1.2M |
| Cost of Revenue | - | - | - | $0 | - | - | - | - | - | - | - |
| SG&A Expense | $30.3M | $29.4M | $21.8M | $17.7M | $15.3M | $11.9M | $9.2M | $7.8M | $6.2M | $3.5M | $2.8M |
| R&D Expense | $91.9M | $82.7M | $107.9M | $113.8M | $75.5M | $48.5M | $49.3M | $21.2M | $15.1M | $8.7M | $4.6M |
| Operating Income | -$87.5M | -$89.1M | $5.4M | -$111.7M | -$77.4M | -$59.5M | -$58.4M | -$25.2M | -$18.1M | -$237.0K | -$6.2M |
| Income Tax | $0 | $0 | -$691.0K | -$816.0K | -$389.0K | -$204.0K | -$468.0K | -$397.0K | -$201.0K | -$30.0K | -$31.0K |
| Net Income | -$85.5M | -$88.4M | $8.4M | -$106.4M | -$74.0M | -$58.1M | -$57.3M | -$24.7M | -$17.7M | -$4.0M | -$6.3M |
| EPS (Basic) | -$19.12 | -$1.74 | $0.18 | -$2.49 | -$2.06 | - | - | - | - | - | - |
| EPS (Diluted) | -$19.12 | -$1.74 | $0.18 | -$2.49 | -$2.06 | -$1.86 | -$2.10 | -$1.00 | -$0.85 | -$0.74 | - |
| Shares Outstanding | 4.5M | 53.8M | 53.5M | 49.9M | 46.7M | 39.5M | 32.7M | 27.3M | 27.3M | 22.8M | 4.3M |
| Operating Margin | -209.1% | -386.9% | 4.0% | -561.6% | -574.5% | -6529.6% | -67907.0% | -662.3% | -568.8% | -2.0% | -524.0% |
| Profit Margin | -204.2% | -384.1% | 6.2% | -534.9% | -549.5% | -6380.4% | -66604.7% | -649.2% | -558.5% | -33.1% | -527.0% |